Rankings
▼
Calendar
PLRX Q1 2024 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PLRX
Pliant Therapeutics, Inc.
$85M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$513,000
Operating Income
-$52M
Net Income
-$47M
EPS (Diluted)
$-0.78
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$32M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$522M
Total Liabilities
$84M
Stockholders' Equity
$437M
Cash & Equivalents
$114M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$1M
-100.0%
Gross Profit
-$513,000
$271,000
-289.3%
Operating Income
-$52M
-$42M
-24.5%
Net Income
-$47M
-$38M
-25.1%
← FY 2024
All Quarters
Q2 2024 →